Siblia
Phage Display Vaccines: New Possibilities for Antigen Presentation and Vaccine Research
A 2026 study of a lambda phage platform targeting EGFRvIII highlights the potential of multivalent antigen display, while underscoring the challenges of translating experimental vaccine designs into effective immunization strategies. What the 2026 EGFRvIII Study Demonstrated In March 2026, NIH-affiliated scientists reported a lambda (λ) bacteriophage engineered to display an...
563 Views
© 2026 Siblia Online: 12 Today: 190 Yesterday: 380 This Week: 744 This Month: 744 This Year: 744 Total: 744 Visitor Analytics